Retraction notice to "ATPase inhibitory factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells" [Biomed. Pharmacother. 70 (2015) 90-96].
作者信息
Yin Tao, Lu Li, Xiong Zhiguo, Wei Shaozhong, Cui Diansheng
机构信息
Department of Gastrointestinal Surgery, Hubei Cancer Hospital, Wuhan 430060, China.
出版信息
Biomed Pharmacother. 2023 Apr;160:114281. doi: 10.1016/j.biopha.2023.114281. Epub 2023 Jan 31.
PMID:36725466
Abstract
摘要
相似文献
1
Retraction notice to "ATPase inhibitory factor 1 is a prognostic marker and contributes to proliferation and invasion of human gastric cancer cells" [Biomed. Pharmacother. 70 (2015) 90-96].撤回对“ATP酶抑制因子1是一种预后标志物并促进人胃癌细胞的增殖和侵袭”[《生物医学与药物治疗》70 (2015) 90 - 96]一文的通知。
Biomed Pharmacother. 2023 Apr;160:114281. doi: 10.1016/j.biopha.2023.114281. Epub 2023 Jan 31.
2
Retraction notice to "Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]" [Biomed. Pharmacother. 152 (2022) 113213].对“《‘mPEG-b-P(Glu-co-Phe)纳米颗粒增加20(S)-人参皂苷Rg3的胃滞留时间和胃溃疡治疗效果’的勘误》[生物医学与药物治疗学146 (2022) 112608]”[生物医学与药物治疗学152 (2022) 113213]的撤回通知。
Biomed Pharmacother. 2023 Apr;160:114280. doi: 10.1016/j.biopha.2023.114280. Epub 2023 Jan 31.
3
Retraction notice to "Down-regulation of lncRNA ADAMTS9-AS2 contributes to gastric cancer development via activation of PI3K/Akt pathway" [Biomed. Pharmacother. 107 (2018) 185-193].撤回通知：“lncRNA ADAMTS9-AS2的下调通过激活PI3K/Akt途径促进胃癌发展”[《生物医学与药物治疗》107卷（2018年）第185 - 193页]
Biomed Pharmacother. 2021 Oct;142:112116. doi: 10.1016/j.biopha.2021.112116. Epub 2021 Sep 9.
4
Retraction notice to "miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer" [Biomed. Pharmacother. 95 (2017) 1718-1724].撤回关于“miR-217通过靶向AKT3抑制甲状腺癌的增殖、迁移和侵袭”的通知[《生物医学与药物治疗》95(2017)1718 - 1724]
Biomed Pharmacother. 2024 Feb;171:116187. doi: 10.1016/j.biopha.2024.116187. Epub 2024 Jan 30.
5
Retraction notice to "Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells" [Biomed. Pharmacother. 109 (2019) 2456-2463].对“Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells”[《生物医学与药物治疗》109(2019)2456 - 2463]的撤稿通知
Biomed Pharmacother. 2022 Jun;150:112851. doi: 10.1016/j.biopha.2022.112851. Epub 2022 Mar 24.
6
Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].撤稿通知：“青藤碱通过调控miR-23a抑制前列腺癌细胞的增殖、迁移、侵袭并促进其凋亡”[《生物医学与药物治疗》112卷（2019年）第108592页]
Biomed Pharmacother. 2022 Apr;148:112781. doi: 10.1016/j.biopha.2022.112781. Epub 2022 Mar 7.
7
Retraction notice to "The effect of DNA-PKcs gene silencing on proliferation, migration, invasion and apoptosis, and in vivo tumorigenicity of human osteosarcoma MG-63 cells" [Biomed. & Pharmacother. 96 (2017) 1324-1334].对《DNA-PKcs基因沉默对人骨肉瘤MG-63细胞增殖、迁移、侵袭、凋亡及体内致瘤性的影响》[《生物医学与药物治疗》96(2017)1324 - 1334]的撤稿通知
Biomed Pharmacother. 2023 Jul;163:114745. doi: 10.1016/j.biopha.2023.114745. Epub 2023 May 10.
8
Retraction notice to "MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14" [Biomed. Pharmacother. 98 (2018) 636-642].撤回通知：“MicroRNA-613通过靶向细胞周期蛋白依赖性激酶14抑制胶质瘤细胞的增殖和侵袭”[《生物医学与药物治疗》98(2018)636 - 642]
Biomed Pharmacother. 2024 Apr;173:116383. doi: 10.1016/j.biopha.2024.116383. Epub 2024 Mar 7.
9
Retraction notice to "Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion" [Biomed. Pharmacother. 109 (2019) 1062-1069].撤回声明：“臭椿酮通过上调MDA-MB-231乳腺癌细胞中miR-148a的表达并抑制增殖、迁移和侵袭发挥抗癌作用”[《生物医学与药物治疗》109(2019)1062 - 1069]
Biomed Pharmacother. 2022 Jun;150:112854. doi: 10.1016/j.biopha.2022.112854. Epub 2022 Mar 24.
10
Retraction notice to "Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a" [Biomed. Pharmacother. 114 (2019) 108782].
Biomed Pharmacother. 2022 Feb;146:112626. doi: 10.1016/j.biopha.2022.112626. Epub 2022 Jan 11.
Zotero 插件